MAUSMODELLE UND THERAPEUTISCHE MOLEKÜLE

Patent europeic · EP3609319 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3609319
Numer da la dumonda
EP18719629
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
10-04-2018
Publitgà
19-02-2020
Concedì
26-02-2025
La protecziun finescha il pli tard
09-04-2038
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
A01K 67/0278 (2024.01)
C07K 16/00 (2006.01)
C07K 16/46 (2006.01)
C12N 5/0781 (2010.01)
Prioritad
GB 201705725 10.04.2017
Dumonda PCT
PCT/GB2018/050946 10.04.2018
Publicaziun PCT
WO2018/189520 18.10.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-05-2026

    Midada

    Published in Swissreg on 01.05.2026

  2. 07-01-2026

    Midada

    Published in Swissreg on 07.01.2026

  3. 01-05-2025

    Midada

    Published in Swissreg on 01.05.2025

  4. 26-02-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 26.02.2025

Partidas

Possessur

Genome Research Limited

Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, GB

Inventur

MARTIN, Jolyon Nicolas Edouard

Hinxton Cambridgeshire CB10 1SA, GB

BRADLEY, Allan

Hinxton Cambridgeshire CB10 1SA, GB

Licenziat

Petmedix Ltd.

The Glenn Berge Building 940 Babraham Research Campus, Babraham, Cambridge CB22 3FH, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.